Stocking the Flu Vaccine a Delicate Business; Many U.S. Suppliers, Including Jacksonville-Based PSS, Are Finding Supply and Demand Is Hard to Predict

By Karkaria, Urvaksh | The Florida Times Union, November 4, 2005 | Go to article overview
Save to active project

Stocking the Flu Vaccine a Delicate Business; Many U.S. Suppliers, Including Jacksonville-Based PSS, Are Finding Supply and Demand Is Hard to Predict


Karkaria, Urvaksh, The Florida Times Union


Byline: URVAKSH KARKARIA

PSS World Medical had hoped to distribute 2.1 million doses of flu vaccine to about 6,000 physician offices nationwide. But production delays by manufacturer Chiron Corp. will likely cut the supply in about half, a top PSS executive said.

Before each flu season, the Jacksonville-based medical equipment distributor to physician offices and elder care facilities makes a gamble -- albeit an educated one -- that could cost it millions of dollars.

This year PSS had expected $20 million -- or a little over 1 percent of its 2005 projected revenues -- from vaccine sales, chief operating officer Gary Corless said. The company would not disclose its profit margins on flu vaccines but said sales of the product are expected to generate about $1 million in annual profits.

Corless and his team calculate the annual vaccine order based on projected demand from physician customers, hardly a rock-solid indicator.

Customers can cancel an order if the flu season proves to be sluggish. Some physicians also pre-order from multiple vaccine manufacturers to hedge against a production shortage by any one company.

The cost of misjudging demand can be steep. Overestimating could leave PSS saddled with excess inventory because unused vaccine can't be returned to the manufacturer and must be destroyed by the end of the season.

Buy too little vaccine and Corless will likely get an earful from disgruntled customers.

This makes the flu vaccine distribution business financially iffy -- PSS's vaccine venture has merely broken even over the past decade.

"If we used the normal risk-reward scenario, we would never be in this business," Corless said. "This has a much higher risk for a much lower reward than anything we do."

Yet PSS persists, saying supplying the flu vaccine is an "added service" to its customers who buy its other products from tray tables to diagnostic equipment.

"We are in it because we supply [more than] 100,000 physician offices and they ask us to be in this business," Corless said. "They buy everything else from us. You can't really say, 'Sorry, this one is hard for us, so go somewhere else.

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
Loading One moment ...
Project items
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

Cited article

Stocking the Flu Vaccine a Delicate Business; Many U.S. Suppliers, Including Jacksonville-Based PSS, Are Finding Supply and Demand Is Hard to Predict
Settings

Settings

Typeface
Text size Smaller Larger
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

While we understand printed pages are helpful to our users, this limitation is necessary to help protect our publishers' copyrighted material and prevent its unlawful distribution. We are sorry for any inconvenience.
Full screen

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.

Are you sure you want to delete this highlight?